Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aebi

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|October 23, 1997
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistanceM M de las Alas, S Aebi, D Fink, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2000
Ovarian cancer. an institutional review of patterns of care, health insurance and prognosisS Balli, M F Fey, W Hänggi, et al.
International Journal of Cancer|October 23, 2001
Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabineZ Xu, H Friess, M Solioz, et al.
Genes, Chromosomes & Cancer|April 1, 1997
Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cellsV M Wasenius, A Jekunen, O Monni, et al.
The Pharmacogenomics Journal|March 23, 2016
The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicityS Hamzic, N Wenger, T K Froehlich, et al.
Schweizerische Medizinische Wochenschrift|December 10, 1998
[Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma]G Berclaz, A O Crazzolara, H J Altermatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cellsS Aebi, D Fink, R Gordon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
In vitro antineoplastic activity of a novel lanthionine-containing peptideH Zheng, D Fink, H Li, et al.
British Journal of Anaesthesia|March 31, 2000
Analgesic action of i.v. morphine-6-glucuronide in healthy volunteersT M Buetler, O H Wilder-Smith, C H Wilder-Smith, et al.
Clinical Pharmacology and Therapeutics|February 1, 2017
Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related ToxicityS Hamzic, D Kummer, S Milesi, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|October 23, 1997
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistanceM M de las Alas, S Aebi, D Fink, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2000
Ovarian cancer. an institutional review of patterns of care, health insurance and prognosisS Balli, M F Fey, W Hänggi, et al.
International Journal of Cancer|October 23, 2001
Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabineZ Xu, H Friess, M Solioz, et al.
Genes, Chromosomes & Cancer|April 1, 1997
Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cellsV M Wasenius, A Jekunen, O Monni, et al.
The Pharmacogenomics Journal|March 23, 2016
The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicityS Hamzic, N Wenger, T K Froehlich, et al.
Schweizerische Medizinische Wochenschrift|December 10, 1998
[Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma]G Berclaz, A O Crazzolara, H J Altermatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cellsS Aebi, D Fink, R Gordon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
In vitro antineoplastic activity of a novel lanthionine-containing peptideH Zheng, D Fink, H Li, et al.
British Journal of Anaesthesia|March 31, 2000
Analgesic action of i.v. morphine-6-glucuronide in healthy volunteersT M Buetler, O H Wilder-Smith, C H Wilder-Smith, et al.
Clinical Pharmacology and Therapeutics|February 1, 2017
Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related ToxicityS Hamzic, D Kummer, S Milesi, et al.
Pageof 8